Select a medication above to begin.
Elidel
pimecrolimus topical
Black Box Warnings .
Rare Malignancies
rare malignancies incl. skin and lymphoma reported following topical calcineurin inhibitor use, causal relationship not established; avoid continuous long-term use; limit application to atopic dermatitis areas; not indicated for pts <2 yo
Adult Dosing .
Dosage forms: CRM: 1%
atopic dermatitis, mild-mod
- [apply bid]
- Info: for short-term or intermittent long-term tx; reassess if no improvement in 6wk; do not use occlusive dressings
Peds Dosing .
- Dosage forms: CRM: 1%
atopic dermatitis, mild-mod
- [3-23 mo (off-label)]
- Dose: apply bid; Info: for short-term or intermittent long-term tx; reassess if no improvement in 6wk; do not use occlusive dressings
- [2 yo and older]
- Dose: apply bid; Info: for short-term or intermittent long-term tx; reassess if no improvement in 6wk; do not use occlusive dressings